IPAR’s Outlook Stays Strong Despite Marginal Gross Margin Concerns; Analyst Cites Strong US & European Growth

DA Davidson analyst Linda Bolton Weiser 

DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating on the shares of Inter Parfums Inc (NASDAQ:IPAR) with a price target of $187.

The company reported 2Q23 sales of $309 million, a 26% increase Y/Y. EPS of $1.09 was above the consensus.

The analyst said that the strong performance was driven by both divisions, with European operations +19% and U.S. operations +42%.

The analyst noted that sales in the company’s three largest markets, North America, Western Europe, and Asia Pacific, were +25%, +26%, and +17%, respectively.

The company is seeing travel retail pick up in line with the resumption of international travel, the analyst noted

The analyst added that IPAR’s licensing agreement with luxury fashion house Roberto Cavalli will possibly rake in an estimated sales of about $40 million.

Related: Inter Parfums Pens Exclusive Licensing Deal With Roberto Cavalli

The company raised the FY23 EPS guidance to $4.55 from $4.25 and maintained its sales guidance of $1.30 billion.

The analyst expects gross margin to be down in 2H23 due to stronger euro, mix (higher U.S. division sales), more holiday gift sets vs. last year when there were supply issues, and the flow into the income statement of older, higher cost inventory. 

Price Action: IPAR shares are trading higher by 0.81% at $136.06 on the last check Thursday.

Total
0
Shares
Related Posts
Read More

Disc Reports Topline Results From Phase 2 AURORA Study Of Bitopertin In Patients With Erythropoietic Protoporphyria; Met Primary Endpoint, Demonstrating Dose-Dependent, Statistically Significant Reductions In Protoporphyrin IX; Improved Measures Of Lig…

Met primary endpoint, demonstrating dose-dependent, statistically significant reductions in protoporphyrin IX (PPIX) compared to placebo in both 20 mg and 60 mg dose groupsImproved measures of light tolerance, including

IRON